AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Mouth bacteria linked to increased head and neck cancer risk

More than a dozen bacterial species that live in people's mouths have been linked to a...

Life expectancy gains are slowing, study finds

Life expectancy at birth in the world's longest-living populations has increased by an...

Towards safer epilepsy treatment for pregnant women

New research conducted in organoids is expected to provide pregnant women with epilepsy safer...

Content from other channels on our network

Medline introduces Namic Ready Set Kits

Solventum innovations enabling better, smarter, safer healthcare

Lumia Care expands national network with SA acquisition

Funding to support cervical cancer screening and treatment in the Pacific

Packaged foods: strict salt targets could prevent 40K cardiovascular events

Driving change: how electric vehicles are fuelling Australia's sustainable businesses

CSIRO gathers innovators to tackle plastic waste

Trinasolar launches agrivoltaics project in NZ

South East Water takes home R&D Excellence Award

Mars Petcare unveils renewable energy plan

Seamless modular I/O integration

Coca-Cola invests nearly $100 million in Queensland manufacturing

Endress+Hauser receives IEC 62443‍-‍4‍-‍1 cybersecurity certification

NSW announces TAFE Centre of Excellence in the Hunter

CSP to power pet food manufacturing in Wodonga